EVALUATION OF MADISON 109 LUNG CARCINOMA AS A MODEL FOR SCREENING ANTITUMOR DRUGSROSE WC.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 299-312; BIBL. 15 REF.Article

Maladie cancéreuse vécu psychologique du malade et du médecin = Psychology and tumorsTOUHAMI, M.Espérance médicale. 2004, Vol 11, Num 103, pp 151-152, 2 p.Article

CHARACTERIZATION AND RESPONSIVENESS OF THE MADISON 109 LUNG CARCINOMA TO VARIOUS ANTITUMOR AGENTS.MARKS TA; WOODMAN RJ; GERAN RI et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 8; PP. 1459-1470; BIBL. 18 REF.Article

T AND B LYMPHOCYTES OF IRRADIATED, TUMOR-BEARING MICE TREATED WITH AN IMMUNOSTIMULATOR, PYRANSTYLOS WA; CHIRIGOS MA; LENGEL CR et al.1978; CELL. IMMUNOL.; USA; DA. 1978; VOL. 40; NO 2; PP. 437-444; BIBL. 21 REF.Article

Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan = Immunothérapie du cancer pulmonaire Madison 109 et d'autres tumeurs murines par le lentinaneROSE, W. C; REED, F. C. III; SIMINOFF, P et al.Cancer research (Baltimore). 1984, Vol 44, Num 4, pp 1368-1373, issn 0008-5472Article

T AND B LYMPHOCYTE POPULATIONS OF TUMOR-BEARING MICE TREATED WITH 1,3-BIS(CHLOROETHYL)-1-NITROSOUREA (BCNU) OR PYRANSTYLOS WA; CHIRIGOS MA; LENGEL CR et al.1978; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1978; VOL. 5; NO 3; PP. 165-172; BIBL. 27 REF.Article

Potentiation of nonspecific immunotherapy of experimental lung metastases by indomethacinSCHULTZ, R. M; ALTOM, M. G.Journal of immunopharmacology. 1983, Vol 5, Num 4, pp 277-290, issn 0163-0571Article

Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanomaBOUSQUET, P. F; PAULSEN, L. A; FONDY, C et al.Cancer research (Baltimore). 1990, Vol 50, Num 5, pp 1431-1439, issn 0008-5472Article

Effects of group B Streptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumorsTHURMAN, G. B; RUSSEL, B. A; YORK, G. E et al.Journal of cancer research and clinical oncology. 1994, Vol 120, Num 8, pp 479-484, issn 0171-5216Article

Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase : 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarbazone (3-amp), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-Ap) and its water-soluble prodrugsJUN LI; ZHENG, Li-Mou; KING, Ivan et al.Current medicinal chemistry. 2001, Vol 8, Num 2, pp 121-133, issn 0929-8673Article